betulinic acid has been researched along with plicamycin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, WC; Chen, SY; Hsu, TI; Huang, ST; Hung, JJ; Su, WC; Wang, MC; Yeh, YM | 1 |
1 other study(ies) available for betulinic acid and plicamycin
Article | Year |
---|---|
Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Betulinic Acid; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin A2; Cysteine Endopeptidases; Down-Regulation; Endopeptidases; Female; HeLa Cells; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, Transgenic; Nuclear Proteins; Pentacyclic Triterpenes; Phosphorylation; Plicamycin; Proteasome Endopeptidase Complex; Retinoblastoma Protein; Sp1 Transcription Factor; Sumoylation; Transcription Factors; Transcriptome; Triterpenes; Ubiquitin; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays | 2012 |